Brief: Sedana Medical May See Seasonally Lower Sales In Q2 And Q3
April 25 (Reuters) - Sedana Medical AB (publ)
SEDANA.ST :
* WE MAY SEE SEASONALLY LOWER SALES IN Q2 AND Q3 AS A
FUNCTION OF
LESS BUSY INTENSIVE CARE UNITS
* TIMELINE WITH REGARDS TO US LAUNCH REMAINS UNCHANGED; WE
ARE
WORKING TOWARDS AN NDA SUBMISSION IN Q1 OF 2025
Source text for Eikon: ID:nWkr4rM9Dr
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln